It has been suggested that probiotics could reduce the incidence of infectious complications in patients with severe acute pancreatitis. This well-designed RCT showed an increased mortality in ...
A new prediction model for infected pancreatic necrosis (IPN) in patients with acute pancreatitis (AP) offers a groundbreaking approach to improving patient outcomes.
US FDA approves Ionis Pharma’s Tryngolza to treat adults living with familial chylomicronemia syndrome as an adjunct to diet: Carlsbad, California Monday, December 23, 2024, 15: ...
We read with great interest the study by Tang et al,1 published in this issue of Polish Archives of Internal Medicine, which assessed sex differences in cardiovascular diseases (CVDs) among patients ...
Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) announced today that the U.S. Food and Drug Administration (FDA) has approved TRYNGOLZA™ (olezarsen) as an adjunct to diet to reduce triglycerides in adults ...
APACHE II, Acute Physiology and Chronic Health Evaluation II; AUC, area under the ROC curve; BISAP, Beside Index for Severity in Acute Pancreatitis; ROC, receiver operating characteristics ...